Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Psychiatry Northwest is a specialized mental health clinic based in Seattle, Washington, focusing on advanced interventional psychiatric treatments for mood disorders and ADHD. The center is a leading regional provider of Transcranial Magnetic Stimulation (TMS), a non-invasive neuromodulation therapy utilized for patients with treatment-resistant depression. In addition to TMS, the clinic offers Spravato (esketamine) nasal spray treatments, comprehensive ADHD evaluations, and traditional medication management services. Their clinical approach emphasizes evidence-based, technology-driven psychiatry to assist patients who have not achieved remission through standard pharmacological interventions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Psychiatry Northwest.